APA

Anderson A. E., Lorenzi A. R., Pratt A., Wooldridge T., Diboll J., Hilkens C. M. U. & Isaacs J. D. (20121002). Immunity 12 years after alemtuzumab in RA: CD5⁺ B-cell depletion, thymus-dependent T-cell reconstitution and normal vaccine responses. : Rheumatology (Oxford, England).

Chicago

Anderson Amy E, Lorenzi Alice R, Pratt Arthur, Wooldridge Tom, Diboll Julie, Hilkens Catharien M U and Isaacs John D. 20121002. Immunity 12 years after alemtuzumab in RA: CD5⁺ B-cell depletion, thymus-dependent T-cell reconstitution and normal vaccine responses. : Rheumatology (Oxford, England).

Harvard

Anderson A. E., Lorenzi A. R., Pratt A., Wooldridge T., Diboll J., Hilkens C. M. U. and Isaacs J. D. (20121002). Immunity 12 years after alemtuzumab in RA: CD5⁺ B-cell depletion, thymus-dependent T-cell reconstitution and normal vaccine responses. : Rheumatology (Oxford, England).

MLA

Anderson Amy E, Lorenzi Alice R, Pratt Arthur, Wooldridge Tom, Diboll Julie, Hilkens Catharien M U and Isaacs John D. Immunity 12 years after alemtuzumab in RA: CD5⁺ B-cell depletion, thymus-dependent T-cell reconstitution and normal vaccine responses. : Rheumatology (Oxford, England). 20121002.